Showing results (61-70 of 306) with videos related to

Sort By:
Pageof 31
Transplantation|June 9, 2001
Complement activation products in plasma after heart transplantation in humansH Vallhonrat, W W Williams, G W Dec, et al.
Transplantation|February 12, 1999
Evolving trends in liver transplantation: an outcome and charge analysisJ R Gilbert, M Pascual, D A Schoenfeld, et al.
Archives of Surgery (Chicago, Ill. : 1960)|June 1, 1990
A randomized clinical trial of prophylactic OKT3 monoclonal antibody in liver allograft recipientsA B Cosimi, R L Jenkins, R J Rohrer, et al.
Transplantation|November 1, 1986
OKT3 monoclonal antibody plasma levels during therapy and the subsequent development of host antibodies to OKT3G Goldstein, A J Fuccello, D J Norman, et al.
Transplantation|October 17, 2001
Postmenopausal tubo-ovarian abscess due to Pseudomonas aeruginosa in a renal transplant patient: a case report and review of the literatureJ El Khoury, M M Stikkelbroeck, A Goodman, et al.
Clinical Immunology and Immunopathology|May 1, 1987
Plasma interleukin 2 receptor levels in renal allograft recipientsR B Colvin, T C Fuller, L MacKeen, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 17, 2000
Prevalence of hepatitis C virus-associated mixed cryoglobulinemia after liver transplantationG A Abrahamian, A B Cosimi, M L Farrell, et al.
World Journal of Nephrology|January 20, 2017
Laparoscopic vs open donor nephrectomy: Lessons learnt from single academic center experienceGeorgios Tsoulfas, Polyxeni Agorastou, Dicken S C Ko, et al.
Diagnostic Immunology|January 1, 1983
Monitoring immunosuppression following renal transplantationJ V Giorgi, A B Cosimi, R B Colvin, et al.
Immunology Today|November 18, 1998
Chronic rejection and chronic cyclosporin toxicity in renal allograftsM Pascual, R D Swinford, J R Ingelfinger, et al.
Pageof 31